Kyowa Hakko Kirin reported JPY40.78B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Astellas Pharma JPY 197B 14.32B Jun/2025
Chugai Pharma JPY 28.41B 5.17B Jun/2025
Daiichi Sankyo JPY 180.35B 27.86B Jun/2025
Eisai JPY 100.16B 6.34B Jun/2025
Kyowa Hakko Kirin JPY 40.78B 1.26B Jun/2025
M3 JPY 26.06B 170M Jun/2025
Otsuka Holdings JPY 239.48B 6.99B Jun/2025
Shionogi JPY 25.82B 2.87B Jun/2025
Sumitomo Dainippon JPY 35.66B 13.91B Jun/2025
Takeda JPY 255.89B 39.98B Jun/2025
Terumo JPY 91.98B 8.58B Jun/2025